Concord Medical unit issues HK$68M 2% bonds
Concord Medical Services Holdings Limited reported that its subsidiary, Concord Healthcare Group Co., Ltd., completed an issue of 2% convertible bonds due 2027 with an aggregate principal amount of HK$68 million.
Rhea-AI Filing Summary
Concord Medical Services Holdings Limited reported that its subsidiary, Concord Healthcare Group Co., Ltd., completed an issue of 2% convertible bonds due 2027 with an aggregate principal amount of HK$68 million. The transaction was completed on May 13, 2026 under a placing and subscription agreement dated May 10, 2026.
Haitong International Securities Company Limited acted as placing agent and Dragon Merit Holdings Limited was the subscriber. Concord Healthcare is listed on the Main Board of the Hong Kong Stock Exchange, and its annual report information is available on the HKSE website.
Positive
- None.
Negative
- None.
Key Figures
Convertible bond principal: HK$68 million
Coupon rate: 2%
Maturity year: 2027
+2 more
5 metrics
Convertible bond principal
HK$68 million
Aggregate principal amount of 2% convertible bonds due 2027
Coupon rate
2%
Interest rate on Concord Healthcare convertible bonds
Maturity year
2027
Maturity of the 2% convertible bonds
Completion date
May 13, 2026
Date the bond issue was completed
Agreement date
May 10, 2026
Date of placing and subscription agreement
Key Terms
convertible bonds, placing and subscription agreement, foreign private issuer, Main Board of The Stock Exchange of Hong Kong Limited
4 terms
convertible bonds financial
"completed the issue of 2% convertible bonds due 2027 in the aggregate principal amount of HK$68 million"
A convertible bond is a loan a company issues that pays regular interest and can be exchanged for a fixed number of the company’s shares under specified terms. It matters to investors because it combines the steady income and lower downside risk of a bond with the upside potential of owning stock—like holding a ticket that can be cashed for equity if the share price rises—affecting returns, risk, and shareholder dilution.
placing and subscription agreement financial
"in accordance with the placing and subscription agreement dated May 10, 2026"
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Main Board of The Stock Exchange of Hong Kong Limited regulatory
"a company listed on the Main Board of The Stock Exchange of Hong Kong Limited"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What financing transaction did Concord Medical (CCM) disclose in this 6-K?
Concord Medical disclosed that its subsidiary Concord Healthcare issued 2% convertible bonds due 2027 with an aggregate principal amount of HK$68 million. The bonds were issued under a placing and subscription agreement completed on May 13, 2026.
What are the key terms of Concord Healthcare’s new convertible bonds?
The bonds carry a 2% interest rate and mature in 2027, with an aggregate principal amount of HK$68 million. They were placed pursuant to a May 10, 2026 agreement with Haitong International Securities Company Limited.
Who participated in Concord Healthcare’s HK$68 million bond issue?
Haitong International Securities Company Limited served as the placing agent, and Dragon Merit Holdings Limited acted as the subscriber. These parties participated under a placing and subscription agreement dated May 10, 2026 for the 2% convertible bonds.
When was Concord Healthcare’s 2% convertible bond issue completed?
The issue of Concord Healthcare’s 2% convertible bonds due 2027 was completed on May 13, 2026. This completion followed a placing and subscription agreement entered into on May 10, 2026 with the placing agent and subscriber.
Where can investors find Concord Healthcare’s HKSE annual report information?
Annual report information for Concord Healthcare, listed on the Main Board of the Hong Kong Stock Exchange under stock code 2453.HK, is accessible through the HKSE’s website at www.hkexnews.hk. The company’s H share listing was previously announced on January 9, 2024.
AI-generated analysis. How Rhea-AI works. Not financial advice.
